Thor-2队列2》中口服厄达非替尼对卡麦特-桂林杆菌无反应、高危非肌浸润性膀胱癌且伴有Fgfr3/2改变的患者的最新疗效和安全性

{"title":"Thor-2队列2》中口服厄达非替尼对卡麦特-桂林杆菌无反应、高危非肌浸润性膀胱癌且伴有Fgfr3/2改变的患者的最新疗效和安全性","authors":"J.W.F. Catto, S.A. Hussain, B. Tran, Géraldine Pignot, Viraj Master, M. Rouprêt, Andrea Tubaro, Nobuaki Shimizu, N. Vasdev, H. Nishiyama, S. Daneshmand, Yuji Miura, Piotr L Chlosta, H.J. Cutuli, M. Luz, L. Crow, V. Naini, Spyros Triantos, M. Baig, G. Steinberg","doi":"10.1016/j.urolonc.2024.01.161","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"6 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"UPDATED EFFICACY AND SAFETY OF ORAL ERDAFITINIB IN PATIENTS WITH BACILLUS CALMETTE-GUÉRIN–UNRESPONSIVE, HIGH-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2 COHORT 2\",\"authors\":\"J.W.F. Catto, S.A. Hussain, B. Tran, Géraldine Pignot, Viraj Master, M. Rouprêt, Andrea Tubaro, Nobuaki Shimizu, N. Vasdev, H. Nishiyama, S. Daneshmand, Yuji Miura, Piotr L Chlosta, H.J. Cutuli, M. Luz, L. Crow, V. Naini, Spyros Triantos, M. Baig, G. Steinberg\",\"doi\":\"10.1016/j.urolonc.2024.01.161\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":506909,\"journal\":{\"name\":\"Urologic Oncology: Seminars and Original Investigations\",\"volume\":\"6 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologic Oncology: Seminars and Original Investigations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.urolonc.2024.01.161\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}